Metabolic and sympathovagal effects of bolus insulin glulisine versus basal insulin glargine therapy in people with type 2 diabetes: A randomized controlled study

por Takeshita, Yumie, Tanaka, Takeo, Wakakuri, Hitomi, Kita, Yuki, Kanamori, Takehiro, Takamura, Toshinari
Publicado 2020

Autoimmune Polyglandular Syndrome Type 3 with Anorexia

por Kahara, Toshio, Wakakuri, Hitomi, Takatsuji, Juri, Motoo, Iori, Shima, Kosuke R., Ishikura, Kazuhide, Usuda, Rika, Noda, Yatsugi
Publicado 2012

Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: A randomized, parallel-group study

por Takeshita, Yumie, Takamura, Toshinari, Kita, Yuki, Otoda, Toshiki, Kato, Ken-ichiro, Wakakuri, Hitomi, Yamada, Masayuki, Misu, Hirofumi, Matsushima, Yukiko, Kaneko, Shuichi
Publicado 2015

Pleiotropic effects of sitagliptin versus voglibose in patients with type 2 diabetes inadequately controlled via diet and/or a single oral antihyperglycemic agent: a multicenter, r...

por Matsushima, Yukiko, Takeshita, Yumie, Kita, Yuki, Otoda, Toshiki, Kato, Ken-ichiro, Toyama-Wakakuri, Hitomi, Akahori, Hiroshi, Shimizu, Akiko, Hamaguchi, Erika, Nishimura, Yasuyuki, Kanamori, Takehiro, Kaneko, Shuichi, Takamura, Toshinari
Publicado 2016